HSBC HOLDINGS PLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 275 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$566,468
-88.7%
10,823
-91.2%
0.00%
-100.0%
Q1 2024$5,001,381
+35.2%
123,060
+22.9%
0.00%0.0%
Q4 2023$3,698,414
+23.1%
100,101
+27.7%
0.00%0.0%
Q3 2023$3,005,538
+43.4%
78,404
+35.0%
0.00%
+50.0%
Q2 2023$2,095,363
-45.4%
58,058
-42.3%
0.00%
-60.0%
Q1 2023$3,837,705
-19.8%
100,564
+19.5%
0.01%
-16.7%
Q4 2022$4,786,997
+46.0%
84,122
+1.5%
0.01%
+20.0%
Q3 2022$3,279,000
+46.8%
82,904
+63.2%
0.01%
+66.7%
Q2 2022$2,234,000
-3.2%
50,786
-12.2%
0.00%0.0%
Q1 2022$2,308,000
-9.0%
57,838
-8.0%
0.00%
+50.0%
Q4 2021$2,536,000
+34.0%
62,840
+35.1%
0.00%0.0%
Q3 2021$1,892,000
+280.7%
46,524
+148.4%
0.00%
+100.0%
Q3 2020$497,000
+170.1%
18,732
+80.8%
0.00%
Q1 2020$184,000
-21.4%
10,362
-20.9%
0.00%
Q4 2019$234,000
-59.6%
13,107
-64.9%
0.00%
-100.0%
Q3 2019$579,000
+116.9%
37,342
+125.0%
0.00%
Q1 2019$267,000
+70.1%
16,597
+54.6%
0.00%
Q4 2018$157,000
-15.6%
10,738
-42.8%
0.00%
Q4 2016$186,000
+64.6%
18,782
+47.5%
0.00%
-100.0%
Q2 2012$113,00012,7320.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Third Security, LLC 19,816,162$195,784,0009.33%
BB BIOTECH AG 5,846,564$57,764,0002.74%
QVT Financial LP 4,556,090$45,014,0002.44%
Parametrica Management Ltd 29,578$292,0002.21%
SECTORAL ASSET MANAGEMENT INC 4,389,682$43,370,0001.84%
Belmont Global Advisors, Inc. 257,000$2,539,0001.83%
HARVEY CAPITAL MANAGEMENT INC 394,550$3,898,0001.40%
Lombard Odier Asset Management (USA) Corp 1,350,000$13,338,0000.70%
IRIDIAN ASSET MANAGEMENT LLC/CT 6,199,685$61,253,0000.63%
Callan Capital, LLC 199,230$1,968,0000.53%
View complete list of HALOZYME THERAPEUTICS INC shareholders